Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Brentuximab Vedotin × Clear all

Sponsor

Conditions

Hodgkin Disease 24 Lymphoma 14 Lymphoma, Large-Cell, Anaplastic 12 Hematologic Diseases 10 Recurrence 8 Lymphoma, T-Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphatic Diseases 3 Leukemia 3 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Histologic Type 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia, Myeloid, Acute 2 Immunoproliferative Disorders 2 Immunoblastic Lymphadenopathy 2 Immune System Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Testicular Neoplasms 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nonseminomatous germ cell tumor 1 Myelodysplastic Syndromes 1 Mastocytosis, Systemic 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡